Loading ETF profile…
Command Palette
Search for a command to run...
Search for a command to run...
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| CORT | Corcept Therapeutics Inc. | 5.74% | $186.81M |
| NEO | NeoGenomics, Inc. | 5.18% | $168.40M |
| VCYT | Veracyte, Inc. | 5.11% | $166.22M |
| BRKR | Bruker Corporation | 4.23% | $137.55M |
| ILMN | Illumina, Inc. | 4.22% | $137.29M |
| ALKS | Alkermes Plc | 4.18% | $135.87M |
| NTRA | Natera, Inc. | 3.75% | $121.98M |
| NBIX | Neurocrine Biosciences, Inc. | 3.57% | $116.15M |
| AXSM | Axsome Therapeutics, Inc. | 3.57% | $116.14M |
| KRYS | Krystal Biotech, Inc. | 3.54% | $115.16M |
| TECH | Bio-Techne Corporation | 3.47% | $112.76M |
| EXEL | Exelixis, Inc. | 3.37% | $109.75M |
| RGEN | Repligen Corporation | 3.32% | $107.94M |
| INCY | Incyte Corporation | 3.26% | $105.96M |
| BIIB | Biogen Inc. | 3.24% | $105.40M |
| HALO | Halozyme Therapeutics, Inc. | 3.07% | $99.77M |
| VRTX | Vertex Pharmaceuticals Incorporated | 2.99% | $97.21M |
| BMRN | BioMarin Pharmaceutical Inc. | 2.95% | $96.02M |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 2.94% | $95.62M |
| ARGX | argenx SE (ADR) | 2.88% | $93.63M |
| AMGN | Amgen Inc. | 2.84% | $92.39M |
| GMAB | Genmab A/S (ADR) | 2.75% | $89.52M |
| ONC | BeOne Medicines Ltd. (ADR) | 2.75% | $89.45M |
| GILD | Gilead Sciences, Inc. | 2.63% | $85.55M |
| BNTX | BioNTech SE (ADR) | 2.57% | $83.66M |